@article{QIMS11204,
author = {Marie-Tiphaine Falcoz and Nicolas Falvo and Serge Aho-Glélé and Emmanuel Demaistre and Christophe Galland and Sylvain Favelier and Pierre Pottecher and Olivier Chevallier and Bernard Bonnotte and Sylvain Audia and Maxime Samson and Béatrice Terriat and Marco Midulla and Romaric Loffroy and for the Burgundy Research Study Group on Treatment of Venous Diseases},
title = {Endovascular stent placement for chronic post-thrombotic symptomatic ilio-femoral venous obstructive lesions: a single-center study of safety, efficacy and quality-of-life improvement},
journal = {Quantitative Imaging in Medicine and Surgery},
volume = {6},
number = {4},
year = {2016},
keywords = {},
abstract = {Background: Post-thrombotic syndrome (PTS) is a frequent complication of deep vein thrombosis (DVT) despite adequate treatment. Venous angioplasty and stent placement has been progressively used to restore and maintain venous patency in PTS patients. This study reports our single-center experience with the use of endovascular treatment for chronic post-thrombotic symptomatic ilio-femoral venous obstructive lesions.
Methods: A prospective mono-centric observational cohort study of PTS patients with chronic symptomatic ilio-femoral venous obstructive lesions referred for endovascular treatment was conducted from March 2012 to April 2016. Procedure consisted in recanalization, pre-dilation and self-expandable stenting of stenotic or occluded iliac and/or femoral veins. Severity of PTS, quality-of-life and treatment outcomes were assessed using Villalta scale and Chronic Venous Insufficiency Questionnaire (CIVIQ-20) at baseline and 3 months after the procedure. Imaging follow-up was based on duplex ultrasound (US) and computed tomography (CT).
Results: Twenty-one patients (11 females, 10 males; median age, 41 years; range, 32–60) were included. Recanalization and stenting was successfully accomplished in all prime procedures, 4 patients benefitted from an additional procedure. Immediate technical success rate was 96% considering 25 procedures, performed without any complications. Median follow-up was 18 months (range, 6–30) with a 90.5% stent patency rate. Villalta score significantly decreased from baseline compared with 3 months after the procedure [14 (range, 11–22) and 5 (range, 1–10), respectively, P},
issn = {2223-4306}, url = {https://qims.amegroups.org/article/view/11204}
}